Latest Revenue Growth News

BKI Investment Company Limited reported a solid half-year performance for December 2024, maintaining stable revenue and lifting its fully franked dividend by 1%. The company also introduced a neutralised Dividend Reinvestment Plan to better align shareholder interests and capital structure.

Ava Risk Group reports a 20% revenue increase in H1 FY2025, driven by robust sales order intake and strategic expansion in key security sectors.

Activeport has successfully closed a $6.1 million capital raise, including a significant placement to new institutional investor MWP Partners, positioning the company for accelerated growth in the global telecommunications and data centre software markets.

PolyNovo Limited reports a robust 22.8% revenue increase in 1H FY25, driven by strong U.S. and international sales growth and progressing FDA approval efforts for its NovoSorb platform.

RLF AgTech has secured a strategic trading agreement with National Rural Independent Ltd, enabling distribution of its crop nutrition products through 152 stores nationwide, marking a pivotal step in its Australian market expansion.

Connexion Mobility reports robust Q2 FY25 results with revenue and net profit surging, driven by subscription growth and strategic product launches. The company’s focus on user engagement and marketplace expansion signals promising long-term shareholder value.

VIP Gloves Limited reports modest net operating cash flow for September 2024 and outlines plans to restart manufacturing by year-end, supported by asset sales and improved market conditions.

Spacetalk Limited reports a robust 12% increase in Annual Recurring Revenue to $11 million, driven by a 21% jump in paid mobile subscribers, signaling strong momentum and international ambitions.

RLF AgTech has secured a strategic trading agreement with National Rural Independent Ltd, enabling distribution of its crop nutrition products through 152 NRI stores nationwide. This partnership aims to boost RLF’s Australian market presence and support sustainable farming practices.

Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.

Telix Pharmaceuticals has exceeded its full-year 2024 revenue guidance, driven by strong sales of its prostate cancer diagnostic Illuccix® and strategic pipeline advancements.

Way2VAT has locked in A$1.3 million through convertible notes aimed at bolstering working capital and accelerating client expansion, pending shareholder approval for conversion.